List view / Grid view

News

KOMBIGLYZE™ XR tablets approved in the US for the treatment of type 2 diabetes mellitus in adults

5 November 2010 | By

AstraZeneca and Bristol-Myers Squibb Company today announced that the US Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment of type 2 diabetes in adults. KOMBIGLYZE XR is the first and only once-a-day metformin extended-release (XR) plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering strong glycaemic control across…

Wyatt Technology MALS Detectors

4 November 2010 | By The Scott Partnership

Enable Pharmaceutical Manufacturers to Perform Easy and Reliable Transmembrane Protein Characterization...